Alexion
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Objective: To evaluate the efficacy of satralizumab (SA237) in subgroups of the SAkuraSky study (NCT02028884). Background…
Epidemiological data on prevalence and incidence of chronic hypoparathyroidism are still scarce. This study aimed to establish…
Background The immune system has been shown to be important in the pathophysiology of MDS. Adaptive immunity relies on T cells…
No matter where you look in biopharmaceutical boardrooms, gender bias is evident. Is it so difficult to actually acknowledge this…
In the past, thrombotic thrombocytopenic purpura (TTP) was defined as a syndrome of the pentad of thrombocytopenia…
Orphan drug development is already difficult enough. Demanding manufacturers account for the development costs of individual…
To prevent a popular backlash against the spiraling prices of US prescription medicines, industry needs to do more to address out…
In order to bolster its pipeline for rare diseases, Alexion Pharmaceuticals has purchased the privately held biotech company…
Since the early 1990s, the New England-area companies Alexion Pharmaceuticals of Cheshire, Connecticut, and Avant…
Tumor necrosis factor (TNF) antagonists are biologic response modifiers that have significantly improved functional outcomes in…